Back to search
FDAFDA · Food and drugs·Recall number D-395-2014

0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045. NDC #0409-9046-01.

Published January 8, 2014 · Recall initiated: October 11, 2013

Summary

FDA records drug Class II recall D-395-2014, published January 8, 2014 and initiated October 11, 2013. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 65109 vials; Lot: Lot #32-484-EV, 32-485-EV Exp: 2/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.

What to do

Voluntary: Firm initiated · Letter

Get an email if BUPIVACAINE HYDROCHLORIDE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BUPIVACAINE HYDROCHLORIDE
Manufacturer
Hospira Inc.
Distributor
US Nationwide.
Lot
Lot #32-484-EV, 32-485-EV Exp: 2/2015.
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045. NDC #0409-9046-01. recalled?

Yes. FDA published recall D-395-2014 on January 8, 2014. Reported hazard: Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BUPIVACAINE HYDROCHLORIDE.